Developer docs
API playgroundTry for free, no card

Search company profiles

Biotechware

Full company profile

uuid000494p

Namestring
Biotechware
Legal namestring
Aizoi
Websiteurl
biotechware.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Biotechware, which operates under the trade name Aizoi, is an Italian digital health company that has built an integrated telemedicine platform for cardiometabolic screening, diagnosis, and remote patient monitoring, with a particular emphasis on serving retail pharmacies in addition to hospitals, clinics, and individual healthcare professionals. Founded in 2011 and headquartered in Torino, the company combines proprietary medical hardware, a CE-marked (CE 0426) cloud platform, and a 24/7 cardiology reporting service into a single vertically integrated offering aimed at decentralizing cardiovascular diagnostics outside of traditional hospital settings.

The product portfolio spans five core medical devices and a cloud backbone. The TrAIcorder uses proprietary remote photoplethysmography (rPPG) technology with AI-driven analysis to perform contactless cardiometabolic screening of 25+ vital and metabolic parameters in 60 seconds without a blood draw. The CardioPad Lite is a next-generation resting electrocardiograph with health card integration; the Eclipse PRO is a dynamic ECG Holter recorder with up to 14 days of battery life; the TensioPod is an ambulatory blood pressure monitor; and the Kit Telemonitoraggio is a pre-configured six-parameter remote monitoring kit (oxygen saturation, heart rate, temperature, blood pressure, body weight, blood glucose). The Piattaforma Cloud aggregates device data, supports HL7 and API integration, and feeds a Centro Cardiologico reporting service coordinated by Prof. Sebastiano Marra that delivers ECG, Holter, blood pressure, and telemonitoring reports on flexible turnaround times from 20 minutes to 24 hours.

The company monetizes through a combination of hardware sales (devices), recurring platform subscriptions for the cloud, and professional reporting services (telereferring, Holter, ECG, and telemonitoring). Pricing is quote-based and contract terms are typically multi-year for enterprise customers. Distribution is omnichannel within Italy: direct field sales to hospitals, clinics, and government health authorities (such as ASL TO3); a pharmacy network reaching retail consumers; and a healthcare professional partner channel. The company reports an installed base of 2,500+ devices, 1,000+ active partners, and 400,000+ examinations processed through the platform. Cumulative disclosed funding is approximately $2.77M across a 2016 seed round and a 2017 round led by MedMe; the firm remains private and operates at an 11-50 employee scale.

Short descriptiontext

Biotechware, operating as Aizoi, is an Italian digital health company that combines proprietary cardiometabolic medical devices, a CE-marked cloud platform, and a 24/7 telereferring service to deliver screening, diagnosis, and remote monitoring for hospitals, pharmacies, and clinicians across Italy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTorino, Italy
HQ citystring
Torino
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac diagnostics, telemedicine platform, remote patient monitoring, medical device manufacturing, digital health services
Industry4 codes
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Cardiometabolic Diagnostics & Telemedicine
Social media profiles4 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of proprietary medical devices including ECG Holter, blood pressure monitors, and cardiometabolic screening devices

aizoi.com
2Software/Platform Services
TypeSubscription Recurring
Description

Cloud platform subscription for data management, analysis, and telemedicine services

aizoi.com
3Diagnostic Services
TypeProfessional Services
Description

Telereferring and telemonitoring services with flexible reporting timelines from 20 minutes to 24 hours

aizoi.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Custom enterprise pricing for hospitals and clinics
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing varies by institution size and service requirements

aizoi.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Biotechware (commercial brand: Aizoi) sells an integrated cardiometabolic diagnostics and telemedicine offering that pairs proprietary medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) with a CE-marked cloud platform and a 24/7 cardiologist-led telereporting service. The platform enables contactless screening, ECG/Holter/blood-pressure reporting, and remote patient monitoring for hospitals, clinics, pharmacies, and healthcare professionals in Italy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 60-second contactless cardiometabolic screening without blood draw
+3 more records
Product overview1 text field

Aizoi offers a holistic approach to easy and safe cardiometabolic diagnostics through digital health and telemedicine solutions for screening, diagnosis, and monitoring. The portfolio includes medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) supported by a cloud platform (Piattaforma Cloud) and professional medical reporting services (Centro Cardiologico, ECG a riposo, ECG Holter, Holter Pressorio, Telerefertazione, Telemonitoraggio). The platform enables integration with HL7 and API, providing healthcare professionals with tools for early cardiovascular disease detection, diagnosis, and post-diagnosis patient rehabilitation monitoring.

Product and service9 records
1TrAIcorder
CategoryMedical device
Description

Contactless medical device for cardiometabolic screening that completes an assessment in 60 seconds without a blood draw, using rPPG technology and AI to analyze more than 25 vital and metabolic parameters. Designed for healthcare professionals, pharmacies, and clinical settings.

2CardioPad Lite
CategoryMedical device
Description

Next-generation electrocardiograph that speeds up clinical workflows through patient data scanning via health card, an interactive guide for electrode placement, and direct report viewing/printing from a tablet. Intended for clinicians performing resting ECG examinations.

3Eclipse PRO
CategoryMedical device
Description

Dynamic ECG (Holter) recorder designed for simplicity and patient comfort, with an integrated display, lightweight ergonomic design, 3 or 10 channel recording, 24/48-hour to 14-day battery life, and a waterproof rechargeable USB battery. Used for ambulatory cardiac monitoring.

4TensioPod
CategoryMedical device
Description

Lightweight, silent, easy-to-wear blood pressure monitoring device using the oscillometric method with Inflation Measurement Technology, offering automatic wake/sleep period recording and up to 5 days of recording capacity for ambulatory blood pressure monitoring.

5Kit Telemonitoraggio
CategoryMedical device kit
Description

Pre-configured remote patient monitoring kit that measures six parameters (oxygen saturation, heart rate, temperature, blood pressure, body weight, and blood glucose) and ships with a pre-configured smartphone and SIM for automatic data transfer to the Aizoi Cloud Platform.

6Piattaforma Cloud (Aizoi Cloud Platform)
CategorySoftware platform
Description

CE 0426-certified cloud platform for registering, analyzing, and sharing patient data, designed to be flexible and customizable with HL7 and API integration and accessible from PC and tablet without installation. Forms the data backbone connecting all Aizoi devices and services.

7Centro Cardiologico (Telereferring Service)
CategoryProfessional diagnostic service
Description

24/7 medical reporting center coordinated by Prof. Sebastiano Marra, staffed by cardiologists with proven telemedicine experience, providing reporting for ECG, Holter, and blood pressure monitoring analyses for partner hospitals, clinics, pharmacies, and physicians.

8ECG a riposo (Resting ECG Reporting Service)
CategoryProfessional diagnostic service
Description

Resting ECG examination reporting service with flexible turnaround times ranging from 20 minutes to 24 hours depending on client needs.

9ECG Holter Reporting Service
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

iRhythm's Zio service provides continuous ambulatory cardiac monitoring with AI-based ECG analysis and a cloud reporting platform — directly mirroring Aizoi's combination of wearable cardiac devices, cloud platform, and specialist reporting for arrhythmia and cardiometabolic diagnostics.

2Vitaphone
TypeRegional player
Description

German-headquartered provider of telehealth, telemonitoring, and RPM services with a particular strength in cardiology across DACH and broader Europe. Comparable in offering RPM kits, cloud platform, and cardiac telemedical reporting, primarily serving European markets.

TypeBroad incumbent
Description

UK-based provider of telecare and telehealth solutions, including RPM for chronic cardiac and metabolic conditions across Europe. Comparable in tele-monitoring kits, cloud infrastructure, and managed services, but with a much broader care portfolio spanning elderly and chronic care.

TypeEmerging player
Description

European connected-health company providing cellular gateways and cloud infrastructure to connect medical devices for RPM. Adjacent peer with overlapping technology stack (device connectivity + cloud platform) used by cardiac and chronic-disease monitoring programs similar to Aizoi's Kit Telemonitoraggio.

TypeBroad incumbent
Description

Medtronic's LINQ insertable cardiac monitor streams data through the CareLink network, and the company sells broader cardiovascular devices. Comparable as a remote cardiac monitoring platform, though Medtronic focuses on implantable diagnostics and operates at vastly larger global scale.

6Cardiolex
TypeDirect peer
Description

Swedish company providing ECG analysis services, Holter, and cloud-based cardiology reporting — closely matching Aizoi's diagnostic services and cloud-platform offering, though serving a Nordic/European footprint rather than Italy.

TypeBroad incumbent
Description

Philips acquired BioTelemetry and offers a broad portfolio of ambulatory ECG, Holter, and remote cardiac monitoring services. Highly comparable as a cardiology-focused monitoring services and device provider, but operating globally at much larger scale with a wider product portfolio.

TypeBroad incumbent
Description

GE Healthcare sells resting ECG, Holter, and stress testing systems widely used in hospitals and clinics, plus the MUSE cardiology information system. Overlaps with Aizoi's hospital-facing diagnostic devices and cloud-based reporting infrastructure, but as part of a much broader imaging and monitoring franchise.

TypeEmerging player
Description

Swiss company offering cuffless continuous blood pressure monitoring and a connected health platform with AI analysis — closely comparable to Aizoi's contactless TrAIcorder and TensioPod continuous BP monitoring approach for cardiometabolic screening and management.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biotechware

Cardiometabolic Diagnostics & Telemedicinebiotechware.com

Biotechware, operating as Aizoi, is an Italian digital health company that combines proprietary cardiometabolic medical devices, a CE-marked cloud platform, and a 24/7 telereferring service to deliver screening, diagnosis, and remote monitoring for hospitals, pharmacies, and clinicians across Italy.

What Biotechware does

Biotechware, which operates under the trade name Aizoi, is an Italian digital health company that has built an integrated telemedicine platform for cardiometabolic screening, diagnosis, and remote patient monitoring, with a particular emphasis on serving retail pharmacies in addition to hospitals, clinics, and individual healthcare professionals. Founded in 2011 and headquartered in Torino, the company combines proprietary medical hardware, a CE-marked (CE 0426) cloud platform, and a 24/7 cardiology reporting service into a single vertically integrated offering aimed at decentralizing cardiovascular diagnostics outside of traditional hospital settings.

The product portfolio spans five core medical devices and a cloud backbone. The TrAIcorder uses proprietary remote photoplethysmography (rPPG) technology with AI-driven analysis to perform contactless cardiometabolic screening of 25+ vital and metabolic parameters in 60 seconds without a blood draw. The CardioPad Lite is a next-generation resting electrocardiograph with health card integration; the Eclipse PRO is a dynamic ECG Holter recorder with up to 14 days of battery life; the TensioPod is an ambulatory blood pressure monitor; and the Kit Telemonitoraggio is a pre-configured six-parameter remote monitoring kit (oxygen saturation, heart rate, temperature, blood pressure, body weight, blood glucose). The Piattaforma Cloud aggregates device data, supports HL7 and API integration, and feeds a Centro Cardiologico reporting service coordinated by Prof. Sebastiano Marra that delivers ECG, Holter, blood pressure, and telemonitoring reports on flexible turnaround times from 20 minutes to 24 hours.

The company monetizes through a combination of hardware sales (devices), recurring platform subscriptions for the cloud, and professional reporting services (telereferring, Holter, ECG, and telemonitoring). Pricing is quote-based and contract terms are typically multi-year for enterprise customers. Distribution is omnichannel within Italy: direct field sales to hospitals, clinics, and government health authorities (such as ASL TO3); a pharmacy network reaching retail consumers; and a healthcare professional partner channel. The company reports an installed base of 2,500+ devices, 1,000+ active partners, and 400,000+ examinations processed through the platform. Cumulative disclosed funding is approximately $2.77M across a 2016 seed round and a 2017 round led by MedMe; the firm remains private and operates at an 11-50 employee scale.

Biotechware firmographics

Firmographics
Name
Biotechware
Legal name
Aizoi
Website
https://biotechware.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Biotechware, operating as Aizoi, is an Italian digital health company that combines proprietary cardiometabolic medical devices, a CE-marked cloud platform, and a 24/7 telereferring service to deliver screening, diagnosis, and remote monitoring for hospitals, pharmacies, and clinicians across Italy.
Ownership category
akta.pro rank

Biotechware industry classification

Industry
Product category
Cardiometabolic Diagnostics & Telemedicine
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Cardiac diagnostics
  • Telemedicine platform
  • Remote patient monitoring
  • Medical device manufacturing
  • Digital health services

Where Biotechware is headquartered

Location

Headquarters

HQ city
Torino
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Biotechware business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: Sale of proprietary medical devices including ECG Holter, blood pressure monitors, and cardiometabolic screening devices
  2. Software/Platform Services: Cloud platform subscription for data management, analysis, and telemedicine services
  3. Diagnostic Services: Telereferring and telemonitoring services with flexible reporting timelines from 20 minutes to 24 hours

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing for hospitals and clinics

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Biotechware product offering

Product offering

Core offering

Biotechware (commercial brand: Aizoi) sells an integrated cardiometabolic diagnostics and telemedicine offering that pairs proprietary medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) with a CE-marked cloud platform and a 24/7 cardiologist-led telereporting service. The platform enables contactless screening, ECG/Holter/blood-pressure reporting, and remote patient monitoring for hospitals, clinics, pharmacies, and healthcare professionals in Italy.

Product overview

Aizoi offers a holistic approach to easy and safe cardiometabolic diagnostics through digital health and telemedicine solutions for screening, diagnosis, and monitoring. The portfolio includes medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) supported by a cloud platform (Piattaforma Cloud) and professional medical reporting services (Centro Cardiologico, ECG a riposo, ECG Holter, Holter Pressorio, Telerefertazione, Telemonitoraggio). The platform enables integration with HL7 and API, providing healthcare professionals with tools for early cardiovascular disease detection, diagnosis, and post-diagnosis patient rehabilitation monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

  • TrAIcorder Contactless medical device for cardiometabolic screening that completes an assessment in 60 seconds without a blood draw, using rPPG technology and AI to analyze more than 25 vital and metabolic parameters. Designed for healthcare professionals, pharmacies, and clinical settings.
  • CardioPad Lite Next-generation electrocardiograph that speeds up clinical workflows through patient data scanning via health card, an interactive guide for electrode placement, and direct report viewing/printing from a tablet. Intended for clinicians performing resting ECG examinations.
  • Eclipse PRO Dynamic ECG (Holter) recorder designed for simplicity and patient comfort, with an integrated display, lightweight ergonomic design, 3 or 10 channel recording, 24/48-hour to 14-day battery life, and a waterproof rechargeable USB battery. Used for ambulatory cardiac monitoring.
  • TensioPod Lightweight, silent, easy-to-wear blood pressure monitoring device using the oscillometric method with Inflation Measurement Technology, offering automatic wake/sleep period recording and up to 5 days of recording capacity for ambulatory blood pressure monitoring.
  • Kit Telemonitoraggio Pre-configured remote patient monitoring kit that measures six parameters (oxygen saturation, heart rate, temperature, blood pressure, body weight, and blood glucose) and ships with a pre-configured smartphone and SIM for automatic data transfer to the Aizoi Cloud Platform.
  • Piattaforma Cloud (Aizoi Cloud Platform) CE 0426-certified cloud platform for registering, analyzing, and sharing patient data, designed to be flexible and customizable with HL7 and API integration and accessible from PC and tablet without installation. Forms the data backbone connecting all Aizoi devices and services.
  • Centro Cardiologico (Telereferring Service) 24/7 medical reporting center coordinated by Prof. Sebastiano Marra, staffed by cardiologists with proven telemedicine experience, providing reporting for ECG, Holter, and blood pressure monitoring analyses for partner hospitals, clinics, pharmacies, and physicians.
  • ECG a riposo (Resting ECG Reporting Service) Resting ECG examination reporting service with flexible turnaround times ranging from 20 minutes to 24 hours depending on client needs.
  • ECG Holter Reporting Service

Quantifiable outcome

  • 60-second contactless cardiometabolic screening without blood draw
  • +3 more outcomes

Companies that use Biotechware

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Biotechware technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Biotechware partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Biotechware competitors and assessment

Company assessment

Direct peers

  • iRhythm Technologies: iRhythm's Zio service provides continuous ambulatory cardiac monitoring with AI-based ECG analysis and a cloud reporting platform — directly mirroring Aizoi's combination of wearable cardiac devices, cloud platform, and specialist reporting for arrhythmia and cardiometabolic diagnostics.
  • Cardiolex: Swedish company providing ECG analysis services, Holter, and cloud-based cardiology reporting — closely matching Aizoi's diagnostic services and cloud-platform offering, though serving a Nordic/European footprint rather than Italy.

Regional players

  • Vitaphone: German-headquartered provider of telehealth, telemonitoring, and RPM services with a particular strength in cardiology across DACH and broader Europe. Comparable in offering RPM kits, cloud platform, and cardiac telemedical reporting, primarily serving European markets.

Broad incumbents

  • Tunstall Healthcare: UK-based provider of telecare and telehealth solutions, including RPM for chronic cardiac and metabolic conditions across Europe. Comparable in tele-monitoring kits, cloud infrastructure, and managed services, but with a much broader care portfolio spanning elderly and chronic care.
  • Medtronic (LINQ / CareLink Network): Medtronic's LINQ insertable cardiac monitor streams data through the CareLink network, and the company sells broader cardiovascular devices. Comparable as a remote cardiac monitoring platform, though Medtronic focuses on implantable diagnostics and operates at vastly larger global scale.
  • Philips (BioTelemetry / Remote Cardiac Monitoring): Philips acquired BioTelemetry and offers a broad portfolio of ambulatory ECG, Holter, and remote cardiac monitoring services. Highly comparable as a cardiology-focused monitoring services and device provider, but operating globally at much larger scale with a wider product portfolio.
  • GE Healthcare (MUSE and ECG/Holter portfolio): GE Healthcare sells resting ECG, Holter, and stress testing systems widely used in hospitals and clinics, plus the MUSE cardiology information system. Overlaps with Aizoi's hospital-facing diagnostic devices and cloud-based reporting infrastructure, but as part of a much broader imaging and monitoring franchise.

Emerging players

  • eDevice: European connected-health company providing cellular gateways and cloud infrastructure to connect medical devices for RPM. Adjacent peer with overlapping technology stack (device connectivity + cloud platform) used by cardiac and chronic-disease monitoring programs similar to Aizoi's Kit Telemonitoraggio.
  • Hilo (formerly Aktiia): Swiss company offering cuffless continuous blood pressure monitoring and a connected health platform with AI analysis — closely comparable to Aizoi's contactless TrAIcorder and TensioPod continuous BP monitoring approach for cardiometabolic screening and management.

Others

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biotechware social profiles

Digital presence

Biotechware financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biotechware leadership team

Management profile

Number of profiles

Profiles3 records

Biotechware funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biotechware M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotechware

What does Biotechware do?

Biotechware (commercial brand: Aizoi) sells an integrated cardiometabolic diagnostics and telemedicine offering that pairs proprietary medical devices (TrAIcorder, CardioPad Lite, Eclipse PRO, TensioPod, Kit Telemonitoraggio) with a CE-marked cloud platform and a 24/7 cardiologist-led telereporting service. The platform enables contactless screening, ECG/Holter/blood-pressure reporting, and remote patient monitoring for hospitals, clinics, pharmacies, and healthcare professionals in Italy.

Is Biotechware a public or private company?

Biotechware is a private company. It is classified as venture growth investor backed and is currently operating.

When was Biotechware founded?

Biotechware was founded in 2011. It employs 11 to 50 people.

Where is Biotechware based?

Biotechware is headquartered in Torino, Italy, in the Europe region.

How does Biotechware make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are software/Platform Services and diagnostic Services.

Who are Biotechware's main competitors?

Direct peers on record are iRhythm Technologies and Cardiolex. Vitaphone is listed as a regional player. Broad incumbents are Tunstall Healthcare, Medtronic (LINQ / CareLink Network), Philips (BioTelemetry / Remote Cardiac Monitoring) and GE Healthcare (MUSE and ECG/Holter portfolio). Emerging players are eDevice and Hilo (formerly Aktiia). Boston Scientific (Preventice Solutions) is listed as an others.

Does Biotechware have an API?

No public API is recorded for Biotechware.

What industry is Biotechware in?

Biotechware's product category is Cardiometabolic Diagnostics & Telemedicine. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales